States join antitrust suit against ‘pharma bro’ Shkreli

Six state attorneys have joined a suit filed against incarcerated ‘pharma bro’ Martin Shkreli and his company Vyera Pharmaceuticals for allegedly monopolising the market for a life-saving drug.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

Americas

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

30 July 2020 Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission.

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

More on this story

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

Americas

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

30 July 2020 Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission.

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

More on this story

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

Americas

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

30 July 2020 Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission.

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

States join antitrust suit against ‘pharma bro’ Shkreli

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features